Oncology & Liquid Biopsy Biomarker

8 Items

This section welcomes research on circulating biomarkers relevant to cancer detection, progression, prognosis, and treatment monitoring. Areas include circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles, tumor‑derived proteins, liquid biopsy technologies, and biomarkers for minimal residual disease or therapy response. Both discovery‑focused and clinically oriented studies are included.

Associate Editor: Prof. Roger Chammas  | Ongoing call for papers

All Items

  • Circulating free and low-density lipoprotein-bound GD2 can compete in vitro with neuroblastoma cells for binding therapeutic anti-GD2 antibodies

    Christina Turn, Christine M. Busch, Cara Toland, Hamid Bassiri, Michael D. Hogarty, Frank M. Balis
    69-77
    DOI: https://doi.org/10.33393/jcb.2026.3797

  • Relevance of existing blood-based biomarkers for detection of hepatocellular carcinoma: a prospective case-control study

    Mohammed Farouk, Kunkumabalasubramanian Sreedurgalakshmi, Jeyanthi Rebecca
    58-68
    DOI: https://doi.org/10.33393/jcb.2026.3774

  • Circulating miRNAs (135a-5p, 646 AND 1271-5P) in breast cancer diagnosis and staging: integrative network and functional analysis

    Asmaa Abdel-Hamed, Marina Barsom, Mahmoud Kamel, Dina Abo-Elmatty, Abdullah Gibriel
    47-57
    DOI: https://doi.org/10.33393/jcb.2026.3840

  • From glycosylation to inflammation: insights from NMR-Derived GlycA and GlycB

    Dalia Ahmed, Karla Christina Sousa Silva, Mariet Wium, Luiz Fernando Zerbini, Stefano Cacciatore
    38-46
    DOI: https://doi.org/10.33393/jcb.2026.3772

  • Transcriptome biomarkers of colon cancer liver metastasis response to neoadjuvant triplet chemotherapy: a case series

    Nataliya Babyshkina, Tatyana Dronova, Dmitry Eremin, Alexey Dobrodeev, Dmitry Kostromitskiy, Sergey Vtorushin, Polina Gervas, Sergey Afanasiev, Nadejda Cherdyntseva
    48-53
    DOI: https://doi.org/10.33393/jcb.2025.3597

  • Erratum in “Diagnostic value of carcinoembryonic antigen, cancer antigen 15-3, and cell-free DNA as blood biomarkers in early detection of canine mammary tumor”

    Diksha Singh, Prashant P. Rokade, Neeraj K. Gangwar, Mukul G. Gabhane, Sunil Malik, Kavisha Gangwar, Shyama N. Prabhu, Renu Singh, D.D. Singh, Sonam Kumari, Soumen Chaudhary, Jitendra K. Choudhary
    46-47
    DOI: https://doi.org/10.33393/jcb.2025.3657

  • Diagnostic value of carcinoembryonic antigen, cancer antigen 15-3, and cell-free DNA as blood biomarkers in early detection of canine mammary tumor

    Diksha Singh, Prashant P. Rokade, Neeraj K. Gangwar, Mukul G. Gabhane, Sunil Malik, Kavisha Gangwar, Shyama N. Prabhu, Renu Singh, D.D. Singh, Sonam Kumari, Soumen Chaudhary, Jitendra K. Choudhary
    30-38
    DOI: https://doi.org/10.33393/jcb.2025.3564

  • A comparison of inflammatory markers’ potential to predict weight loss in advanced cancer: a prospective observational study

    Ola Magne Vagnildhaug, Ragnhild H. Habberstad, Øyvind Salvesen, Trude R. Balstad, Asta Bye, Olav Dajani, Stein Kaasa, Pål Klepstad, Tora S. Solheim
    12-20
    DOI: https://doi.org/10.33393/jcb.2025.3510